Course Information
Course Semester Plan
Course Information
| No | Module name | Pharmacogenomics and Pharmacogenetics |
| 1 | Courses code | P20.01009 |
| 2 | Study loads | 2 credits |
| 3 | Semester | First Semester |
| 4 | Precondition | there is no |
| 5 | Competence | Upon completion of this course, students are expected to be able to: 1. List and explain the psychochemical properties of solute and solvent that affect solubility, stability, and other biopharmaceutical properties used in the development of pharmaceutical & biopharmaceutical dosage forms, traditional medicines & supplements, and cosmetics 2. Show contributions in individual or group projects. 3. Summarize information and communicate its development obtained from group experience |
| 6 | Elements of competency | MKK |
| 7 | Type competency | Supporting competence |
| 8 | Syllabus | 1-2. Introduction to Pharmacogenomics and pharmacogenetics, as well as genotyping methods; 3-5. Pharmacogenetics and race / ethnicity, pharmacogenetic Adverse Drug Reactions, Potential of social, ethical, and legal issues of pharmacogenetic development; 6-7. Pharmacogenetics and oncology, pharmacogenetics and infectious diseases; 8. Mid-term exam; 9-10. Polymorphisms in the treatment of cardiovascular and respiratory diseases, pharmacogenetics and metabolic diseases; 11-14. Pharmacogenomics of human p-glycoproteins, drug transporters, drug metabolizing enzymes, and drug targeting enzymes; 15. Case study discussion: Pharmacogenomic contribution to drug therapy: Warfarin, Clopidogrel,: Irinotecan, Aspirin etc; 16. Final Exam |
| 9 | Attribute to soft skills | ethics, discipline, awareness |
| 10 | Learning methods | Lectures and Discussion |
| 11 | Learning media | the LCD viewer, lapto p, white board and “online” (Google Meet) |
| 12 | Appraisal | Presentation, Midterm Exam, and Final Exam |
| 13 | Lecturer | Apt. Melisa Intan Barliana, Dr.Med.Sc.. Dr. Apt. Tina Rostinawati, M.Si. and Apt, Taofik Rosdiana, Ph.D. |
| 14 | References |
|
Course Semester Plan